PINNA, ANNALISA
 Distribuzione geografica
Continente #
EU - Europa 59.286
NA - Nord America 2.821
AS - Asia 1.281
SA - Sud America 186
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 63.608
Nazione #
IT - Italia 58.595
US - Stati Uniti d'America 2.780
SG - Singapore 513
CN - Cina 423
UA - Ucraina 177
BR - Brasile 146
VN - Vietnam 142
SE - Svezia 136
DE - Germania 102
GB - Regno Unito 78
FI - Finlandia 68
FR - Francia 53
HK - Hong Kong 49
IN - India 28
CA - Canada 19
KR - Corea 19
JP - Giappone 18
MX - Messico 17
BD - Bangladesh 13
BE - Belgio 13
AR - Argentina 11
RU - Federazione Russa 11
IL - Israele 10
PK - Pakistan 10
IQ - Iraq 9
NL - Olanda 9
VE - Venezuela 9
PL - Polonia 8
TR - Turchia 8
ZA - Sudafrica 8
ES - Italia 7
ID - Indonesia 7
CZ - Repubblica Ceca 6
MA - Marocco 5
SA - Arabia Saudita 5
CO - Colombia 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
CL - Cile 3
EC - Ecuador 3
EG - Egitto 3
ET - Etiopia 3
EU - Europa 3
IR - Iran 3
KE - Kenya 3
KZ - Kazakistan 3
PE - Perù 3
PY - Paraguay 3
TH - Thailandia 3
UY - Uruguay 3
AU - Australia 2
CH - Svizzera 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
IE - Irlanda 2
KH - Cambogia 2
LT - Lituania 2
MY - Malesia 2
NO - Norvegia 2
PH - Filippine 2
RO - Romania 2
UZ - Uzbekistan 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CM - Camerun 1
DO - Repubblica Dominicana 1
GI - Gibilterra 1
GT - Guatemala 1
HR - Croazia 1
JO - Giordania 1
LB - Libano 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 63.608
Città #
Cagliari 57.536
Uta 902
Ashburn 281
Singapore 272
Fairfield 250
Chandler 238
Woodbridge 237
Ann Arbor 150
San Jose 136
Wilmington 113
Dallas 112
Seattle 111
Houston 97
Nyköping 96
Beijing 91
Cambridge 91
Boardman 83
Jacksonville 82
Dearborn 71
New York 66
Shanghai 54
Los Angeles 53
The Dalles 42
Hong Kong 41
Nanjing 39
Santa Clara 37
Ho Chi Minh City 33
Helsinki 32
Council Bluffs 30
Boston 28
Lauterbourg 25
Munich 23
Dong Ket 22
Hanoi 21
Seoul 19
Hefei 17
São Paulo 17
Milan 16
Frankfurt am Main 15
Guangzhou 14
San Diego 14
Brussels 13
Tokyo 13
Rome 12
Buffalo 11
Toronto 11
Haiphong 10
Nanchang 10
Redondo Beach 10
Sassari 10
Shenyang 10
Chicago 9
Falls Church 9
Hebei 9
London 9
Brooklyn 7
Jinan 7
Mexico City 7
Redwood City 7
Turku 7
Beersheba 6
Da Nang 6
Jiaxing 6
Kunming 6
Mountain View 6
New Delhi 6
Oristano 6
Padova 6
Phoenix 6
Columbus 5
Johannesburg 5
Norwalk 5
Poplar 5
Pune 5
Rio de Janeiro 5
Tianjin 5
Warsaw 5
Caracas 4
Cardiff 4
Grottammare 4
Istanbul 4
Montreal 4
Sestu 4
Shenzhen 4
Stockholm 4
Washington 4
Zhengzhou 4
Addis Ababa 3
Alexandria 3
Asunción 3
Atlanta 3
Baghdad 3
Bangkok 3
Belo Horizonte 3
Brasília 3
Bắc Ninh 3
Bến Tre 3
Changsha 3
Chengdu 3
Chennai 3
Totale 61.961
Nome #
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward 3.642
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 3.544
Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway 3.017
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists 2.937
Role of adenosine A2A receptors in motor control: relevance to Parkinson’s disease and dyskinesia 2.778
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice 2.762
Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease 2.685
Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease 2.627
Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l-DOPA-induced rotational behavior in a rodent model of Parkinson's disease 2.525
Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease 2.512
Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age 2.464
The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging 2.385
L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies 2.347
A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: The case of adenosine A2A receptor antagonists 2.318
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug 2.106
Farmaci antiparkinsoniani ed attivi in altri disturbi motori 1.828
Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration 1.804
Caffeine consumption and changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine 1.791
Pharmacological therapy of Parkinson's disease: current options and new avenues 1.774
null 1.651
Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat 1.649
Antiparkinsonian actions and interactions of adenosine antagonists 1.641
Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats 1.208
Adenosine A2A receptor antagonist treatment of Parkinson’s disease 1.141
Adenosine A2A receptor antagonists and Parkinson’s disease: state of the art and future directions 1.134
null 1.012
null 967
Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists 951
null 801
Characterization of Nasco grape pomace-loaded nutriosomes and their neuroprotective effects in the MPTP mouse model of Parkinson’s disease 744
Fos expression induced by olanzapine and risperidone in the central extended amygdala 705
Influence of Age and Genetic Background on Ethanol Intake and Behavioral Response Following Ethanol Consumption and During Abstinence in a Model of Alcohol Abuse 692
null 410
Farmaci antiparkinsoniani ed attivi in altri disturbi motori 405
Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats 276
Extract from Nasco pomace loaded in nutriosomes exerts anti-inflammatory effects in the MPTP mouse model of Parkinson's disease 180
Positive relation between dopamine neuron degeneration and metabolic connectivity disruption in the MPTP plus probenecid mouse model of Parkinson's disease 154
A2A Adenosine Receptor Antagonists and Their Efficacy in Rat Models of Parkinson’s Disease 144
Early α-synuclein/synapsin III co-accumulation, nigrostriatal dopaminergic synaptopathy and denervation in the MPTPp mouse model of Parkinson's Disease 86
Totale 63.797
Categoria #
all - tutte 76.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.837 0 0 0 0 0 0 0 0 0 790 614 433
2021/20223.056 317 232 151 142 220 225 284 189 218 351 323 404
2022/20234.735 455 676 566 405 420 425 236 285 314 333 414 206
2023/20244.061 199 201 148 258 399 665 659 300 172 282 339 439
2024/20255.398 730 945 849 883 440 560 531 67 167 72 81 73
2025/20262.446 227 108 233 161 244 187 682 172 162 270 0 0
Totale 63.797